NCT07894458
MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Two-year recurrence-free survival rate
Timeframe: Time from curative surgery to confirmation of clinical progression (recurrence or metastasis) within two years.
Secondary (2)
Overall survival
Timely diagnosis rate by the novel MRD monitoring technique
Arms and interventions
MRD-Guided Adaptive Postoperative Management GroupExperimental
Other: Adaptive therapy of de-escalation and escalation based on MRD testing and pathological response
Sites
1 site in 1 country
- Peking University People's HospitalBeijing, Beijing Municipality, China